Henock Saint-Jacques is a Cardiology physician affiliated with NYU Langone Health. OpenAlex indexes 12 publications with 311 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1787 Madison Ave
Suite 50c
New York, NY 100354518
Telephone
212-348-9400Registry record last updated 3 Oct 2011.
Industry payments
43 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- SCPHARMACEUTICALS INC.Program year202518 payments
- AGEPHA Pharma FZ LLCProgram year20259 payments
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
68.6%Statin14.7%Atorvastatin Calcium52%Rosuvastatin Calcium48%Part D≥70 patientsBeta blocker10.3%Metoprolol Succinate61%Carvedilol33%Metoprolol Tartrate6%Part D<11 patients+ 18 more classes in this area
Metabolism & gastrointestinal
14.8%SGLT2 inhibitor5.6%Jardiance79%Farxiga21%Part D≥28 patientsGLP-1 receptor agonist2.9%Ozempic100%Part D≥17 patients+ 3 more classes in this area
Blood & clotting
4.9%Factor Xa inhibitor3.2%Eliquis78%Xarelto23%Part D<11 patientsP2Y12 inhibitor1.7%Clopidogrel100%Part D≥17 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Diabetes, Heart Failure and Beyond: Elucidating the Cardioprotective Mechanisms of Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors
American Journal of Cardiovascular Drugs
2021 - Exercise-Induced Sustained Ventricular Tachycardia without Structural Heart Disease: A Case Report
American Journal of Case Reports
2020 - Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF
Journal of the American Heart Association
2016 - A Late Case of Ischemic Cerebral Event after Resection of a Left Atrial Myxoma
Case Reports in Neurology
2016
Similar KOLs
Other experts from the same institution or the same specialty.
Gareth Morgan, MD
NYU Langone Health
Nathan Levin, MD
NYU Langone Health
Ira Jacobson, MD
NYU Langone Health
Michael Zelefsky, MD
NYU Langone Health
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”